We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Proposes Annual Reporting in Reclassification of Some Devices
FDA Proposes Annual Reporting in Reclassification of Some Devices
March 6, 2009
Manufacturers of automated blood cell separator devices should submit an annual report to the FDA for three consecutive years if their device was not approved through the PMA process, according to a notice in the Federal Register.